Symbiotec Pharmalab IPO GMP Today
Last updated: 24 Aug 2026, 2:00 am IST
GMP trend
GMP moved from ₹0 on 18 Aug 2026 to ₹409 on 24 Aug 2026.
Day-wise GMP history
| Date | GMP | Expected Return | Subject to Sauda | Est. Listing |
|---|---|---|---|---|
| 24 Aug 2026 | ₹409 | +41.4% | — | ₹1,397 |
| 23 Aug 2026 | ₹409 | +41.4% | ₹4,700 | ₹1,397 |
| 22 Aug 2026 | ₹410 | +41.5% | ₹4,700 | ₹1,398 |
| 21 Aug 2026 | ₹345 | +34.9% | ₹3,900 | ₹1,333 |
| 20 Aug 2026 | ₹270 | +27.3% | ₹3,400 | ₹1,258 |
| 19 Aug 2026 | ₹220 | +22.3% | ₹2,500 | ₹1,208 |
| 18 Aug 2026 | ₹0 | +0.0% | — | ₹988 |
GMP is an unofficial figure sourced from grey market dealers and is not a guarantee of the listing price. Provided for information only, not investment advice. How we source GMP · Disclaimer
Reading this GMP history
How the GMP moved
The first grey market reading in our record for the Symbiotec Pharmalab IPO came in at ₹0 on 18 Aug 2026. The premium peaked at ₹410, roughly +41.5% on the issue price on 22 Aug 2026. The latest reading is ₹409, dated 24 Aug 2026. Start to finish, over 7 days, that is a net rise of ₹409 per share. Day-end readings ranged between ₹0 and ₹410 across 7 days of data — a band of ₹410 that shows how much dealer sentiment shifted while the quote was live.
Kostak and subject-to-sauda
The grey market in this issue went beyond the share premium to application-level deals. The subject-to-sauda rate — what a buyer pays for an application that is honoured only if it wins allotment — stands at ₹4,700 per application as of 23 Aug 2026. Unlike a kostak deal, where an application changes hands at a fixed price regardless of the outcome, a sauda payout depends entirely on the allotment draw. At the prevailing premium, the dealer-estimated profit per lot stands at ₹6,135 on a lot of 15 shares. Both metrics come from the same dealer network as the GMP itself and move with it. Every grey market figure on this page is an unofficial number collected from grey-market dealers; it is not published by the company or the exchanges and is not a guarantee of the actual listing price.
Frequently asked questions
- What is the Symbiotec Pharmalab IPO price band?
- The Symbiotec Pharmalab IPO price band is ₹938 to ₹988 per share, with a lot size of 15 shares.
- What is the Symbiotec Pharmalab IPO GMP today?
- The latest grey market premium for the Symbiotec Pharmalab IPO is ₹409, implying an expected listing near ₹1,397. GMP is an unofficial figure and not a guarantee of the listing price.
- When is the Symbiotec Pharmalab IPO allotment and listing date?
- Allotment is expected on 28 Aug 2026. The shares are scheduled to list on 1 Sept 2026 on NSE and BSE.